Drug Intermediate
Drug Iintermediate
Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].
References:
- [1]. Ma HC, et al. Homochiral Covalent Organic Framework for Catalytic Asymmetric Synthesis of a Drug Intermediate. J Am Chem Soc. 2020 Jul 22;142(29):12574-12578. [Content Brief]
- [2]. Ramachary D B, et al. Development of pharmaceutical drugs, drug intermediates and ingredients by using direct organo‐click reactions[J]. 2008.
All Product Categories
-
Drug Intermediate Related Products (4800)
Related Products (4800)
-
Pyrrole-2-carboxylic acid (Standard)
0 ImagesCat. No.: HY-W001963RCAS No.: 634-97-9Pyrrole-2-carboxylic acid (Standard) is the analytical standard of Pyrrole-2-carboxylic acid (HY-W001963). This product is intended for research and analytical applications. sp. Nov. Pyrrole-2-carboxylic acid shows antibacterial activity and inhibits biofilm formation. Pyrrole-2-carboxylic acid serves as a precursor for various pyrrole derivatives like Clorobiocin (HY-123515), Coumermycin A1 (HY-N7452) in biosynthetic processes.
-
Hemoregulatory peptide 5b
0 ImagesCat. No.: HY-P2158CAS No.: 84588-89-6Hemoregulatory peptide 5b is an acidic pentapeptide and also a selective inhibitor of myeloid hematopoiesis. Hemoregulatory peptide 5b inhibits myeloid hematopoietic colony formation, as well as the proliferation of committed myeloid hematopoietic stem cells and differentiating myeloid cells. Hemoregulatory peptide 5b exerts anticancer effects against mouse breast cancer and rat glioma. Hemoregulatory peptide 5b exhibits dose-dependent complex hematopoietic regulatory effects in vivo. Hemoregulatory peptide 5b can be used in research related to breast cancer, glioma, and lymphoma.
-
Xanomeline-NH-Boc
0 ImagesCat. No.: HY-186320CAS No.: 1018846-42-8Xanomeline-NH-Boc is a derivative of Xanomeline (HY-105182), which serves as the orthosteric pharmacophore of M1/M4 muscarinic agonist 4 (HY-187957) for activating mAChR1/4.
-
Fmoc-Aeg-OtBu
0 ImagesCat. No.: HY-P11692CAS No.: 169396-89-8Fmoc-Aeg-OtBu is an intermediate in solid-phase peptide synthesis, and serves as a building block for introducing pseudoproline motifs or backbone modifications.
-
1-Hydroxy-3-oxodecane-1-sulfonate sodium
0 ImagesCat. No.: HY-186168CAS No.: 118019-64-01-Hydroxy-3-oxodecane-1-sulfonate sodium is a small-molecule acylacetaldehyde that can be used for the preparation of anti-inflammatory and bactericidal preparations.
-
1-epi-Regadenoson ethyl ester
0 ImagesCat. No.: HY-Z9064CAS No.: 2015222-44-11-epi-Regadenoson ethyl ester is an intermediate in the synthesis of αisomer impurity of Regadenoson which is a highly selective adenosine A2A receptor agonist.
-
Protylonolide
0 ImagesCat. No.: HY-N19330CAS No.: 74758-60-4Protylonolide is a precursor of the antibiotic Tylosin (HY-B0519A). Protylonolide can be used in infection-related research.
-
Justalakonin
0 ImagesCat. No.: HY-N21658CAS No.: 602331-39-5Justalakonin is an arylnaphthalene glycoside that is found in Justicia purpurea. Justalakonin exhibits no significant inhibitory effects on lipid peroxidation, COX‑1, or the proliferation of various tumor cells, but possesses COX-2 inhibitory activity.
-
H-Val-Val-OH-13C10,15N2 TFA
0 ImagesCat. No.: HY-126584SSynonyms: Val-val-13C10,15N2H-Val-Val-OH-13C10,15N2 TFA (Val-val-13C10,15N2) is the 13C- and 15N-labeled H-Val-Val-OH (HY-126584). H-VAL-VAL-OH (Val-val) is a dipeptide in which two valine (Val) residues are linked by an amide bond. H-VAL-VAL-OH can be used for the synthesis of some important compounds such as Poststatin (HY-125432).
-
DMBA-SIL-PNP
0 ImagesCat. No.: HY-160703CAS No.: 2923885-47-4DMBA-SIL-PNP (Compound 5) is an intermediate used for preparing Drug-Linker Conjugates, which can be applied in cancer research.
-
3-Methyl-2(5H)-furanone
0 ImagesCat. No.: HY-W142497CAS No.: 22122-36-73-Methyl-2(5H)-furanone is the common structural unit in natural and several synthetic strigolactones, which are germination stimulants for seeds of the parasitic weeds Striga and Orobanche spp..
-
Ranolazine impurity 10
0 ImagesCat. No.: HY-W016487CAS No.: 2210-74-4Ranolazine impurity 10 is an impurity of Ranolazine.
-
Capecitabine 2',3'-diacetate-d11
0 ImagesCat. No.: HY-W765881Capecitabine 2',3'-diacetate-d11 is the deuterium labeled Capecitabine 2',3'-diacetate (HY-W099488). Capecitabine 2',3'-diacetate (Compound 10b) is the prodrug for the antitumor agent Capecitabine (HY-B0016).
-
LBA-NHS
0 ImagesCat. No.: HY-171713CAS No.: 96607-63-5
-
5-endo-Hydroxyborneol
0 ImagesCat. No.: HY-N16572CAS No.: 68738-10-35-endo-Hydroxyborneol is a hydroxylation metabolite of a monoterpene compound. 5-endo-Hydroxyborneol can be used as a drug intermediate to synthesize optically pure compounds.
-
Fmoc-PNA-U-OH
0 ImagesCat. No.: HY-W665456CAS No.: 959151-70-3Fmoc‑PNA‑U‑OH is a peptide nucleic acid monomer that can be used for the synthesis of peptide nucleic acids (PNAs). Fmoc‑PNA‑U‑OH exhibits specific binding to adenine, resistance to enzymatic degradation, and strong hybridization properties. Fmoc‑PNA‑U‑OH can be applied in research fields such as gene diagnosis, molecular biology, and antisense therapy.
-
CLL1-L1
0 ImagesCat. No.: HY-P12362CAS No.: 2763825-83-6CLL1-L1 is a peptide ligand targeting CLL1, which binds to CLL1 on leukemia stem cells and enables selective targeting of CLL1-expressing cells. CLL1-L1 can be covalently coated onto telodendrimer nanomicelles to mediate drug delivery to leukemia stem cells. CLL1-L1 is useful for research related to leukemia drug delivery.
-
Boc-NH-PAB(triacetyl-β-D-glucopyranuronate)-PNP
0 ImagesCat. No.: HY-164340CAS No.: 2874333-81-8Boc-NH-PAB(triacetyl-β-D-glucopyranuronate)-PNP (Compound 16) is a β-glucuronide-type linker precursor that couples with NeoDegrader P1 to synthesize the NeoDegrader P1-β-Glucuronide Linker Complex. Boc-NH-PAB(triacetyl-β-D-glucopyranuronate)-PNP and its derived linker-payload complexes can be used for the research of acute myeloid leukemia.
-
pCR8
0 ImagesCat. No.: HY-174460pCR8 is a CR8 prodrug and anticancer agent responsive to H2O2. pCR8 achieves selective release of CR8 via boronate ester oxidation mediated by elevated hydrogen peroxide levels at tumor sites, self-assembles into nanoparticles, and degrades cell cycle-related proteins. A synergistic effect is produced when pCR8 is used in combination with immune checkpoint inhibitors. pCR8 can be used for the research of triple-negative breast cancer.
